Latest Verenium Corp. (VRNM) Headlines
Corner Bakery Cafe's Rapid California Development Continues With Experienced Franchise Leaders
PR Newswire - Tue Feb 04, 8:00AM CST
Fresh off the heels of a record-breaking 2013, Corner Bakery Cafe announced it has awarded its first multi-unit development agreement of the new year, and plans to open nine new restaurants in the Central Valley area with new franchise partner C&L Cafe, LLC.
Massage Envy Spa to Open in Manhattan, Midtown-West
PR Newswire - Tue Feb 04, 8:00AM CST
Massage Envy Spa, the pioneer and national leader of professional, convenient and affordable massage and spa services, announced today it plans to open a second location in New York City next year. Massage Envy Spa Franchisee Rita Ewing has signed a lease to open her first Massage Envy Spa at 525 West 42nd Street, in Manhattan's West Midtown area.
Processed Poultry Meat Market Worth $ 250,949.50 Million and Poultry Processing Equipment Market Worth $ 3,974.9 Million by 2018
PR Newswire - Thu Jan 30, 5:30AM CST
According to a new market research report, "Processed Poultry Meat & Poultry Processing Equipment Market By Type (Chicken, Turkey, Ducks), By Product Type (Fresh Processed, Raw Cooked, Pre-Cooked, Raw-Fermented, Cured, Dried), By Poultry Meat Processing Equipment Type & By Geography - Global Trends & Forecasts to 2018" published by MarketsandMarkets, Global poultry meat market was $ 179,551.2 million in 2012 and is expected to reach $ 250,949.5 million by 2018, growing at a CAGR of 5.9% from 2013 to 2018. The poultry processing equipment market was worth $ 2,667.0 million in 2012 and is expected to reach $ 3,974.9 million by 2018, growing at a CAGR of 6.7% from 2013.
BASF successfully completes Verenium tender offer
M2 - Fri Nov 01, 5:56AM CDT
BASF [Frankfurt: BAS, LSE: BFA, SWX: AN] today announced that it has successfully completed the previously announced tender offer to purchase all outstanding shares of common stock of Verenium Corporation, San Diego, California, [Nasdaq: VRNM] for US$4.00 per share in cash. The tender offer expired at 9:00 a.m. Eastern Standard Time (USA) on October 31, 2013. As of the expiration of the tender offer, 11,337,044 Verenium shares were validly tendered and not withdrawn in the tender offer, representing approximately 71 % of Verenium's outstanding shares, according to the depositary for the tender offer.
BASF Successfully Completes Verenium Tender Offer
Marketwire - Thu Oct 31, 10:29AM CDT
BASF (FRANKFURT: BAS) (LSE: BFA) (SIX: AN)
Nasdaq stocks posting largest volume increases
AP - Fri Sep 20, 5:05PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of Verenium Corporation
PR Newswire - Fri Sep 20, 1:30PM CDT
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Verenium Corporation ("Verenium" or the "Company") (Nasdaq- VRNM-News) relating to the proposed acquisition by BASF Corporation.
Verenium Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Merger with BASF Corporation
Business Wire - Fri Sep 20, 12:09PM CDT
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating the merger of Verenium Corporation ("Verenium") (NasdaqGM: VRNM) with BASF Corporation for shareholders. Under the terms of the definitive merger agreement, Verenium shareholders will receive only $4.00 in cash for each share owned.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims That the Merger May Not Be in the Best Interest of Investors of Verenium Corporation - VRNM
PR Newswire - Fri Sep 20, 11:54AM CDT
Pomerantz Grossman Hufford Dahlstrom & Gross LLP is investigating claims on behalf of investors of Verenium Corporation ("Verenium" or the "Company") (NASDAQ: VRNM) (ISIN: US92340P2092) (CUSIP: 92340P209) concerning the proposed acquisition of Verenium by BASF Corporation in a transaction valued at approximately $51 million..
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Verenium Corporation Buyout
Business Wire - Fri Sep 20, 10:14AM CDT
Rigrodsky & Long, P.A.:
BASF buying Verenium for about $51.2 million
AP - Fri Sep 20, 5:41AM CDT
SAN DIEGO (AP) — Chemicals company BASF Corp. is buying biotechnology company Verenium for approximately $51.2 million.
BASF Announces Cash Offer to Acquire Specialized Enzyme Biotechnology Company Verenium
Marketwire - Fri Sep 20, 5:03AM CDT
BASF (FRANKFURT: BAS) (LSE: BFA) (SIX: AN) today announced that its U.S. affiliate, BASF Corporation, has entered into an agreement to commence a cash tender offer for all of the outstanding shares of common stock of the biotechnology company Verenium Corporation (NASDAQ: VRNM) for US$4.00 per share. Based on all outstanding shares and including all net financial liabilities, the enterprise value would be approximately US$62 million (approximately EUR 48 million).(1) Verenium is based in San Diego, California, and generated sales of US$57 million in 2012.
Verenium Enters Agreement To Be Acquired By BASF
PR Newswire - Fri Sep 20, 5:00AM CDT
Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes, today announced it has entered into a definitive merger agreement with BASF Corporation, a leading chemicals company, under which BASF will commence a cash tender offer for all of the outstanding shares of Verenium's common stock. This agreement has been unanimously approved by both Verenium's and BASF's Boards of Directors.
Verenium To Present At The Rodman & Renshaw Annual Global Investment Conference
PR Newswire - Wed Sep 04, 7:00AM CDT
Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes, today announced that Jeffrey Black, Chief Financial Officer, will present at the Rodman & Renshaw Annual Global Investment Conference. The presentation is scheduled to begin at 10:50 a.m. ET on Tuesday September 10, 2013 at the Millennium Broadway Hotel in New York City.
Verenium Reports Financial Results for the Second Quarter and Six Months Ended June 30, 2013
PR Newswire - Wed Aug 07, 3:00PM CDT
Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes, today reported operating highlights and financial results for the second quarter and six months ended June 30, 2013.
Verenium To Present At Two Upcoming Conferences
PR Newswire - Thu Aug 01, 7:00AM CDT
Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes, today announced that James Levine, Chief Executive Officer, and Janet Roemer, Chief Operating Officer, will present at two upcoming conferences.
Novus And Verenium Introduce The Newest Addition To Novus's Enzyme Solutions Portfolio: CIBENZA® PHYTAVERSE(TM)
PR Newswire - Fri Jul 26, 7:00AM CDT
Novus International, Inc. and Verenium Corporation (Nasdaq: VRNM) today announced the name of their new phytase enzyme product, CIBENZA® PHYTAVERSETM. This new innovative phytase is specifically designed to unlock more of the hidden nutritional value in phytate for improved animal growth and well-being.
Corner Bakery Cafe's Rapid California Development Continues With Experienced Franchise Leaders
PR Newswire - Tue Feb 04, 8:00AM CST
Fresh off the heels of a record-breaking 2013, Corner Bakery Cafe announced it has awarded its first multi-unit development agreement of the new year, and plans to open nine new restaurants in the Central Valley area with new franchise partner C&L Cafe, LLC.
Massage Envy Spa to Open in Manhattan, Midtown-West
PR Newswire - Tue Feb 04, 8:00AM CST
Massage Envy Spa, the pioneer and national leader of professional, convenient and affordable massage and spa services, announced today it plans to open a second location in New York City next year. Massage Envy Spa Franchisee Rita Ewing has signed a lease to open her first Massage Envy Spa at 525 West 42nd Street, in Manhattan's West Midtown area.
Processed Poultry Meat Market Worth $ 250,949.50 Million and Poultry Processing Equipment Market Worth $ 3,974.9 Million by 2018
PR Newswire - Thu Jan 30, 5:30AM CST
According to a new market research report, "Processed Poultry Meat & Poultry Processing Equipment Market By Type (Chicken, Turkey, Ducks), By Product Type (Fresh Processed, Raw Cooked, Pre-Cooked, Raw-Fermented, Cured, Dried), By Poultry Meat Processing Equipment Type & By Geography - Global Trends & Forecasts to 2018" published by MarketsandMarkets, Global poultry meat market was $ 179,551.2 million in 2012 and is expected to reach $ 250,949.5 million by 2018, growing at a CAGR of 5.9% from 2013 to 2018. The poultry processing equipment market was worth $ 2,667.0 million in 2012 and is expected to reach $ 3,974.9 million by 2018, growing at a CAGR of 6.7% from 2013.
BASF successfully completes Verenium tender offer
M2 - Fri Nov 01, 5:56AM CDT
BASF [Frankfurt: BAS, LSE: BFA, SWX: AN] today announced that it has successfully completed the previously announced tender offer to purchase all outstanding shares of common stock of Verenium Corporation, San Diego, California, [Nasdaq: VRNM] for US$4.00 per share in cash. The tender offer expired at 9:00 a.m. Eastern Standard Time (USA) on October 31, 2013. As of the expiration of the tender offer, 11,337,044 Verenium shares were validly tendered and not withdrawn in the tender offer, representing approximately 71 % of Verenium's outstanding shares, according to the depositary for the tender offer.
BASF Successfully Completes Verenium Tender Offer
Marketwire - Thu Oct 31, 10:29AM CDT
BASF (FRANKFURT: BAS) (LSE: BFA) (SIX: AN)
Nasdaq stocks posting largest volume increases
AP - Fri Sep 20, 5:05PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of Verenium Corporation
PR Newswire - Fri Sep 20, 1:30PM CDT
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Verenium Corporation ("Verenium" or the "Company") (Nasdaq- VRNM-News) relating to the proposed acquisition by BASF Corporation.
Verenium Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Merger with BASF Corporation
Business Wire - Fri Sep 20, 12:09PM CDT
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating the merger of Verenium Corporation ("Verenium") (NasdaqGM: VRNM) with BASF Corporation for shareholders. Under the terms of the definitive merger agreement, Verenium shareholders will receive only $4.00 in cash for each share owned.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims That the Merger May Not Be in the Best Interest of Investors of Verenium Corporation - VRNM
PR Newswire - Fri Sep 20, 11:54AM CDT
Pomerantz Grossman Hufford Dahlstrom & Gross LLP is investigating claims on behalf of investors of Verenium Corporation ("Verenium" or the "Company") (NASDAQ: VRNM) (ISIN: US92340P2092) (CUSIP: 92340P209) concerning the proposed acquisition of Verenium by BASF Corporation in a transaction valued at approximately $51 million..
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Verenium Corporation Buyout
Business Wire - Fri Sep 20, 10:14AM CDT
Rigrodsky & Long, P.A.:
BASF buying Verenium for about $51.2 million
AP - Fri Sep 20, 5:41AM CDT
SAN DIEGO (AP) — Chemicals company BASF Corp. is buying biotechnology company Verenium for approximately $51.2 million.
BASF Announces Cash Offer to Acquire Specialized Enzyme Biotechnology Company Verenium
Marketwire - Fri Sep 20, 5:03AM CDT
BASF (FRANKFURT: BAS) (LSE: BFA) (SIX: AN) today announced that its U.S. affiliate, BASF Corporation, has entered into an agreement to commence a cash tender offer for all of the outstanding shares of common stock of the biotechnology company Verenium Corporation (NASDAQ: VRNM) for US$4.00 per share. Based on all outstanding shares and including all net financial liabilities, the enterprise value would be approximately US$62 million (approximately EUR 48 million).(1) Verenium is based in San Diego, California, and generated sales of US$57 million in 2012.
Verenium Enters Agreement To Be Acquired By BASF
PR Newswire - Fri Sep 20, 5:00AM CDT
Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes, today announced it has entered into a definitive merger agreement with BASF Corporation, a leading chemicals company, under which BASF will commence a cash tender offer for all of the outstanding shares of Verenium's common stock. This agreement has been unanimously approved by both Verenium's and BASF's Boards of Directors.
Verenium To Present At The Rodman & Renshaw Annual Global Investment Conference
PR Newswire - Wed Sep 04, 7:00AM CDT
Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes, today announced that Jeffrey Black, Chief Financial Officer, will present at the Rodman & Renshaw Annual Global Investment Conference. The presentation is scheduled to begin at 10:50 a.m. ET on Tuesday September 10, 2013 at the Millennium Broadway Hotel in New York City.
Verenium Reports Financial Results for the Second Quarter and Six Months Ended June 30, 2013
PR Newswire - Wed Aug 07, 3:00PM CDT
Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes, today reported operating highlights and financial results for the second quarter and six months ended June 30, 2013.
Verenium To Present At Two Upcoming Conferences
PR Newswire - Thu Aug 01, 7:00AM CDT
Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes, today announced that James Levine, Chief Executive Officer, and Janet Roemer, Chief Operating Officer, will present at two upcoming conferences.
Novus And Verenium Introduce The Newest Addition To Novus's Enzyme Solutions Portfolio: CIBENZA® PHYTAVERSE(TM)
PR Newswire - Fri Jul 26, 7:00AM CDT
Novus International, Inc. and Verenium Corporation (Nasdaq: VRNM) today announced the name of their new phytase enzyme product, CIBENZA® PHYTAVERSETM. This new innovative phytase is specifically designed to unlock more of the hidden nutritional value in phytate for improved animal growth and well-being.
